Point-of-care Tests for Bacterial Vaginosis and Candidosis
Validation of the OSOM BVBLUE Test for Bacterial Vaginosis and the SavvyCheck Vaginal Yeast Test for Vaginal Candidosis: A Prospective Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Philipp Foessleitner, MD BSc
- Phone Number: 28220 +43140400
- Email: philipp.foessleitner@meduniwien.ac.at
Study Contact Backup
- Name: Alex Farr, MD PhD
- Phone Number: 28220 +43140400
- Email: alex.farr@meduniwien.ac.at
Study Locations
-
-
-
Vienna, Austria, 1090
- Recruiting
- Medical University of Vienna, Dept. of Obstetrics and Gynecology
-
Contact:
- Philipp Foessleitner, MD BSc
- Phone Number: 28220 +43140400
- Email: philipp.foessleitner@meduniwien.ac.at
-
Contact:
- Alex Farr, MD PhD
- Phone Number: 28220 +43140400
- Email: alex.farr@meduniwien.ac.at
-
Sub-Investigator:
- Herbert Kiss, MD MBA
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- Legal age (Participants must be 18 years or over)
- Singleton pregnancy
- No recent therapy with antibiotics within the last two weeks
- No application of the following in the previous 72 hours before testing: vaginal ointments/crèmes, douches, spermicides, vaginal lubricants or feminine sprays
Exclusion criteria:
- Age below 18 years
- Multiple pregnancy
- Recent treatment with antibiotics
- Application of the following in the previous 72 hours: vaginal ointments/crèmes, douches, spermicides, vaginal lubricants or feminine sprays
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Yeast, control
Women negative for vulvovaginal candidosis on Gram stain smear.
|
Point-of-care test for the detection of vaginal candidosis
|
|
Yeast, study group
Women positive for vulvovaginal candidosis on Gram stain smear.
|
Point-of-care test for the detection of vaginal candidosis
|
|
Bacterial vaginosis, control
Women negative for bacterial vaginosis on Gram stain smear.
|
Point-of-care test for the detection of bacterial vaginosis
|
|
Bacterial vaginosis, study group
Women positive for bacterial vaginosis on Gram stain smear.
|
Point-of-care test for the detection of bacterial vaginosis
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Test result of OSOM BVBLUE Test or SavvyCheck Vaginal Yeast Test
Time Frame: 10 minutes
|
Result of point-of-care test
|
10 minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gestational age of delivery
Time Frame: approx. 6 months
|
To assess preterm delivery rate
|
approx. 6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Herbert Kiss, MD MBA, Medical University of Vienna
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2115-2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.